ES2115816T3 - Derivados macrolidas de 16-eslabones y su procedimiento de preparacion. - Google Patents
Derivados macrolidas de 16-eslabones y su procedimiento de preparacion.Info
- Publication number
- ES2115816T3 ES2115816T3 ES94110679T ES94110679T ES2115816T3 ES 2115816 T3 ES2115816 T3 ES 2115816T3 ES 94110679 T ES94110679 T ES 94110679T ES 94110679 T ES94110679 T ES 94110679T ES 2115816 T3 ES2115816 T3 ES 2115816T3
- Authority
- ES
- Spain
- Prior art keywords
- hydrogen atom
- macrolid
- derivatives
- link
- preparation procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 125000001931 aliphatic group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 239000003120 macrolide antibiotic agent Substances 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE PRESENTAN DERIVADOS MACROLIDOS DE 16 MIEMBROS REPRESENTADOS POR LA FORMULA (I) EN LA QUE R1 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO SUSTITUYENTE QUE PROTEGE UN GRUPO DE HIDROXIL; R2 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO SUSTITUYENTE QUE PROTEGE UN GRUPO DE HIDROXIL; R3 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO DE AZILO ALIFATICO DE CADENA RECTA QUE TIENE ENTRE 2 Y 4 ATOMOS DE CARBONO; Y R4 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO DE AZILO ALIFATICO O AROMATICO DE CADENA RECTA QUE TIENE ENTRE 1 Y 10 ATOMOS DE CARBONO; O UNA SAL FARMACOLOGICAMENTE ACEPTABLE DE LOS MISMOS. TAMBIEN SE PRESENTA UN NUEVO PROCESO PARA PRODUCIR ESTOS DERIVADOS MACROLIDOS DE 16 MIEMBROS.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16941893A JP3023041B2 (ja) | 1993-07-08 | 1993-07-08 | 新規16員環マクロリド誘導体 |
| JP5300686A JPH07149788A (ja) | 1993-11-30 | 1993-11-30 | 新規16員環マクロリド誘導体及びそれらの効率的製造法 |
| JP6105096A JPH07309889A (ja) | 1994-05-19 | 1994-05-19 | 新規16員環マクロリド誘導体及びそれらの新規製造法 |
| JP6126654A JPH07330791A (ja) | 1994-06-08 | 1994-06-08 | 新規16員環マクロリド誘導体及びそれらの新規包括的製造法 |
| JP6145125A JPH0812696A (ja) | 1994-06-27 | 1994-06-27 | 新規16員環マクロリド誘導体及びそれらの効率的製造法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2115816T3 true ES2115816T3 (es) | 1998-07-01 |
Family
ID=27526205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94110679T Expired - Lifetime ES2115816T3 (es) | 1993-07-08 | 1994-07-08 | Derivados macrolidas de 16-eslabones y su procedimiento de preparacion. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5602106A (es) |
| EP (1) | EP0633266B1 (es) |
| KR (1) | KR100360568B1 (es) |
| CN (2) | CN1046534C (es) |
| AT (1) | ATE165604T1 (es) |
| CA (1) | CA2127578A1 (es) |
| DE (1) | DE69409874T2 (es) |
| ES (1) | ES2115816T3 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000073317A1 (fr) * | 1999-06-01 | 2000-12-07 | Meiji Seika Kaisha, Ltd. | Derives de leucomycine modifiee en position 3 |
| DE602007006663D1 (de) | 2006-06-12 | 2010-07-01 | Univ Ramot | Verfahren zur behandlung von krebs |
| CN102344946B (zh) * | 2010-08-02 | 2014-06-25 | 中牧实业股份有限公司 | 一种生物转化合成普拉特霉素a1的方法 |
| KR20140004187A (ko) * | 2011-01-31 | 2014-01-10 | 메이지 세이카 파루마 가부시키가이샤 | 신규 마크로라이드 유도체 |
| CA2894992A1 (en) | 2012-12-24 | 2014-07-03 | Ramot At Tel-Aviv University Ltd. | Agents for treating genetic diseases resulting from nonsense mutations, and methods for identifying the same |
| RU2746047C1 (ru) * | 2017-04-06 | 2021-04-06 | Шенянг Фуянг Фармасьютекал Технолоджи Ко., Лтд. | Применение карримицина и его фармацевтически приемлемой соли для производства медикаментов для лечения и/или профилактики опухоли |
| RU2766176C2 (ru) * | 2017-07-04 | 2022-02-08 | Шенянг Фуянг Фармасьютекал Технолоджи Ко., Лтд. | Применение изовалерил-спирамицина i, ii и/или iii при изготовлении препарата для лечения и/или профилактики опухоли и получения лекарственного препарата |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2638458A1 (fr) * | 1988-10-27 | 1990-05-04 | Adir | Nouveaux derives de la tylosine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| JP3063943B2 (ja) * | 1992-02-26 | 2000-07-12 | 明治製菓株式会社 | 血漿中において抗菌活性の持続する新規16員環マクロリド誘導体及びその合成中間体とそれらの製造法 |
| EP0595303B1 (en) * | 1992-10-29 | 1999-04-14 | Meiji Seika Kaisha Ltd. | 16-Membered macrolide derivatives and process for producing the same |
-
1994
- 1994-07-07 CA CA002127578A patent/CA2127578A1/en not_active Abandoned
- 1994-07-08 AT AT94110679T patent/ATE165604T1/de not_active IP Right Cessation
- 1994-07-08 CN CN94115983A patent/CN1046534C/zh not_active Expired - Fee Related
- 1994-07-08 EP EP94110679A patent/EP0633266B1/en not_active Expired - Lifetime
- 1994-07-08 DE DE69409874T patent/DE69409874T2/de not_active Expired - Fee Related
- 1994-07-08 ES ES94110679T patent/ES2115816T3/es not_active Expired - Lifetime
- 1994-07-08 KR KR1019940016581A patent/KR100360568B1/ko not_active Expired - Fee Related
- 1994-07-08 US US08/271,996 patent/US5602106A/en not_active Expired - Fee Related
-
1998
- 1998-07-23 CN CN98116380A patent/CN1093134C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE165604T1 (de) | 1998-05-15 |
| DE69409874D1 (de) | 1998-06-04 |
| DE69409874T2 (de) | 1999-01-21 |
| CN1219539A (zh) | 1999-06-16 |
| EP0633266B1 (en) | 1998-04-29 |
| US5602106A (en) | 1997-02-11 |
| CN1106818A (zh) | 1995-08-16 |
| KR100360568B1 (en) | 2003-03-12 |
| CA2127578A1 (en) | 1995-01-09 |
| CN1046534C (zh) | 1999-11-17 |
| EP0633266A1 (en) | 1995-01-11 |
| CN1093134C (zh) | 2002-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3019787T3 (en) | 5-o-desosaminylerythronolide a derivative. | |
| TW262474B (es) | ||
| SG49607A1 (en) | 1-methylcarbapenem derivatives and process for preparation thereof | |
| ES2112870T3 (es) | Derivados de acido glicirretico. | |
| EP0531016A3 (en) | Polysulfate of beta-cyclodextrin derivative and process for preparing the same | |
| GR3020682T3 (en) | Use of dioxabicyclo [3.3.0]octane derivatives for the manufacture of a medicament for inhibiting the metabolism of cholesterol. | |
| ES2115816T3 (es) | Derivados macrolidas de 16-eslabones y su procedimiento de preparacion. | |
| HU903880D0 (en) | Process for producing muramyl-dipeptide derivatives and pharmaceutical preparatives containing these compounds | |
| DE69029781D1 (de) | Anthracyclinglycosid-Derivate und Verfahren zu ihrer Herstellung | |
| DE68900638D1 (de) | 4-substituierte anthracyclinone und anthracyclinonglycoside und ihre herstellung. | |
| EP0852231A3 (en) | 16-Membered macrolide derivative having sustained antibacterial activity in plasma, synthesis intermediate thereof and process for producing the same | |
| ES2080068T3 (es) | Derivados de 2-piranona y su procedimiento de preparacion. | |
| HUT52044A (en) | Process for producing pyrrolidine derivatives | |
| HU212807B (en) | Process for producing alpha-methylenecyclopentanone derivatives | |
| TW353071B (en) | Chromene compounds with neutroleptic activity, their preparation and pharmaceutical compositions | |
| GR3030952T3 (en) | Salmycins, a process for their preparation and their use as a pharmaceutical. | |
| IT1249062B (it) | Derivati dell'eserolina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizuini farmaceutiche che li contengono. | |
| GB2232669A (en) | Novel cyclobutane derivative and process for producing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 633266 Country of ref document: ES |